Background and Purpose-Astrocytes, neurons, and microvessels together form a neurovascular unit allowing blood flow to match neuronal activity. Adenosine diphosphate (ADP) is an important signaling molecule in the brain, and dilation in response to ADP is astrocyte-dependent in rats and newborn pigs. Carbon monoxide (CO), produced endogenously by catabolism of heme to CO, iron, and biliverdin via heme oxygenase, is an important cell-signaling molecule in the neonatal cerebral circulation. We hypothesize ADP stimulates CO production by glia limitans astrocytes and that this CO causes pial arteriolar dilation. Methods-Experiments were performed using anesthetized piglet with closed cranial windows, and freshly isolated piglet astrocytes and microvessels. Astrocyte injury was caused by topical application of L-2-alpha aminoadipic acid (2 mmol/L, 5 hours). Cerebrospinal fluid was collected from under the cranial windows for measurement of ADP-stimulated CO production. CO was measured by gas chromatography-mass spectroscopy analysis. Results-Before, but not after, astrocyte injury in vivo, topical ADP stimulated both CO production and dilation of pial arterioles. Astrocyte injury did not block dilation to isoproterenol or bradykinin. Chromium mesoporphyrin, an inhibitor of heme oxygenase, also prevented the ADP-induced increase in cerebrospinal fluid CO and pial arteriolar dilation caused by ADP, but not dilation to sodium nitroprusside. ADP also increased CO production by freshly isolated piglet astrocytes and cerebral microvessels, although the increase was smaller in the microvessels. Conclusions-These data suggest that glia limitans astrocytes use CO as a gasotransmitter to cause pial arteriolar dilation in response to ADP. 
C erebrovascular smooth muscle tone, and thus cerebrovascular resistance, is regulated by a variety of signals coming from nerves, endothelium, pericytes, and astrocytes, which together with the vascular smooth muscle form a neurovascular unit. 1 Astrocytes can respond to synaptic activity and signals from other neurovascular unit components by releasing vasoactive compounds. 2, 3 Astrocytes outnumber neurons in the brain and are remarkably multifunctional cells. 4 A typical astrocyte can send processes to hundreds of synapses. Most astrocytes also extend at least 1 process that contacts a blood vessel. 5, 6 Thus, astrocytes are in a unique position for sensing neuronal activity, integrating that information, and communicating with cerebral blood vessels. 4, 5, 7 Endogenous carbon monoxide (CO) is a gasotransmitter that can be related to neural function 8 and blood flow regulation in the brain. 9 -12 CO is produced physiologically by catabolism of heme via heme oxygenase (HO), with oxidation of NADPH, to CO, iron, and biliverdin. 13 Heme oxygenase-2 (HO-2) is constitutively highly expressed in astrocytes, neurons, and cerebral microvessels. 14 CO production can be controlled by regulation of substrate availability to HO-2 or the effective catalytic activity of HO-2. 15 In the newborn pigs, CO is involved in pial arteriolar responses to neuronal activity, hypoxia, and changing blood pressure. 9, 10, 12, 16 In vivo, topical application of CO dilates pial arterioles in newborn pigs. 10 The vasodilatory effect of CO is caused by activation of Ca 2ϩ -activated K ϩ (K Ca ) channels. 17 Adenosine diphosphate (ADP) is a regulator of cerebral blood flow. 18 ADP can produce endothelium-dependent cerebral vasodilation, 19 which may be mediated in part by nitric oxide (NO) and an endothelium-derived hyperpolarizing factor. 20, 21 In adult rats and newborn pigs, ADP-dependent pial arteriolar dilation is also astrocyte-dependent. 11, 22 Astrocytes and endothelium dependence are consistent with astrocyte-derived CO as a final signal because, in newborn pigs, 5 NO, prostanoids, and cGMP are important as permissive factors enabling vascular responses to CO. 23, 24 The goal of the present study was to address the hypothesis that ADP stimulates production of CO by glia limitans astrocytes and that this CO causes pial arteriolar dilation in the newborn piglet brain.
Materials and Methods

Methods
The animal protocols conform to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were reviewed and approved by the Animal Care and Use Committee of the University of Tennessee Health Science Center. Newborn pigs (1-3 days old; 1-2.5 kg; Bill Nichols Hog Farm, Olive Branch, Mississippi) were anesthetized with ketamine hydrochloride (33 mg/kg, intramuscularly) and acepromazine (3.3 mg/kg, intramuscularly) and maintained on ␣-chloralose (50 mg/kg, intravenously). A catheter was inserted into a femoral artery to monitor blood pressure and to collect blood for measurement of P O2 , P CO2 , and pH. A second catheter was placed in a femoral vein for anesthetic and fluid administration. The animals were intubated, mechanically ventilated, and, if needed, supplemented with O 2 to maintain arterial pH, P O2 , and P CO2 within the normal range. A heating pad was used to maintain the animals at 37.5°C to 38.5°C, which was monitored with a rectal probe.
Materials
Water-soluble adenosine 5Ј-diphosphate monosodium salt was purchased from Calbiochem. The HO inhibitor chromium mesoporphyrin (CrMP) was purchased from Frontier Scientific. All other reagents were purchased from Sigma Chemicals unless otherwise stated.
Cranial Window Placement
The scalp was surgically retracted and a 2-cm-diameter craniotomy was made over the parietal cortex. The dura was cut and all cut edges were retracted over the bone so that the periarachnoid space was not exposed to damaged bone or damaged membranes. A stainless steel and glass window was implanted into the hole and cemented sequentially with bone wax and dental acrylic. The window consisted of 3 parts: a stainless steel ring, a circular glass coverslip, and 3 ports consisting of 17-gauge hypodermic needles attached to 3 precut holes in the stainless steel ring. The space under the window was filled with artificial cerebrospinal fluid (aCSF) equilibrated with 6% CO 2 and 6% O 2 that produced gases and pH within the normal range for cerebral spinal fluid (CSF) (pHϭ7.33-7.40; P CO2 ϭ42-46 mm Hg; P O2 ϭ43-50 mm Hg). Fluid under the cranial window was exchanged through the needles om the sides of the window. Pial arterioles were observed with a dissecting microscope. Diameters were measured with a video micrometer and monitor.
In all experiments, the physiological variables were within normal limits. PaO 2 , Pa CO2 , pH, and mean arterial pressure in these groups did not show any significant differences when initial and final values over the course of the experiments were compared.
In Vivo Experiments
After implantation of the cranial window, at least 30 minutes were allowed before experimentation was begun. Isoproterenol (ISO 10
, and sodium nitroprusside (10 Ϫ6 M) were applied directly to pial arterioles; the maximum diameter attained during a 5-minute period was used for measurement because the onset of dilation after topical application of these agonists is rapid, with maximum diameter typically attained within 3 minutes. The cranial window was flushed with aCSF between experiments, and pial arterioles were allowed to return to control diameter before the next agonist was applied. Control responses were compared with the same treatments after astrocyte injury or HO inhibition.
Glia limitans astrocyte injury was produced by exposing the superficial cortical glia limitans under the cranial window to the selective glia toxin, L-2-␣-aminoadipic acid L-2␣AAA (2 mmol/L for 5 hours). 11, 22, 26, 27 The cellular specificity of L-2␣AAA results from the rapid uptake of the toxin by the cysteine-glutamate antiporter expressed by glia, but not other cells. 28, 29 The precise mechanism underlying the gliotoxicity caused by cellular loading with L-2␣AAA is not known. For these experiments, we modified the method from the one developed to produce removal of the influence of glia limitans astrocyte signals on pial arteriolar responses in adult rats. 22, 27 The inactive isomer, D-2␣ aminoadipic acid (D-2␣AAA; 2 mmol/L for 5 hours), was used as control.
To investigate the contribution of CO produced endogenously by HO to vascular responses, the brain surface under the window was exposed to a HO inhibitor, CrMP (2ϫ10 Ϫ5 M). 10, 29 CrMP was topically applied and, because of its photosensitivity, lights were turned off between measurements.
Cerebral CO Production
Collections of CSF from under the cranial window were made under control conditions and during subsequent ADP treatment before and after treatment with L-2␣AAA. Collections were made after the aCSF had been under the window for 5 minutes. To obtain CSF from under the window, fresh aCSF was injected into 1 of the needle ports on the cranial window and 400 L of displaced CSF was collected in a 2-mL glass bottle using a metal spout on another port. We have previously shown that this collection method produces results after collection from under the window that equate to known concentrations. 12 The total end volume was increased to 1.7 mL, 31 CO standard was added, and the vial was sealed with a rubber and Teflon cap. CO in the headspace gas was measured by gas chromatography-mass spectrometry and quantified by comparison to the 31 CO standard as described previously. 30 
Astrocyte and Microvessel Collection
Microvessels and astrocytes were prepared as described. 11, 25 Briefly, the brain was removed and placed in ice-cold Krebs solution. The brain cortex tissue was minced and gently homogenized in a Dounce homogenizer with a loose pestle. The homogenate was passed through a 300-m nylon mesh screen, and the passage was refiltered through a 60-m nylon mesh screen. The cerebral microvessels were retained on the 60-m filters and the filtrate was the astrocyteenriched fraction of cerebral cortex. Microvessels were washed off the screen by agitation in Krebs and both the microvessels and astrocytes were concentrated by centrifugation. The concentrated cells were resuspended in Krebs.
CO Production by Microvessels and Astrocytes
Freshly isolated cerebral microvessels and astrocytes in 1.7 mL Krebs solution were placed inside 2.0-mL amber vials. For HO and P2Y1 purinergic receptor inhibition, the microvessels and astrocytes were pretreated with CrMP (2ϫ10 Ϫ5 M) or the P2Y1 inhibitor, MRS-2179 (10 mol/L), for 30 minutes before the experiment was started, and the inhibitors were maintained throughout. Vehicle or ADP and the internal standard ( 31 CO) were injected into the bottom of the vial, which was immediately sealed with a rubberized Teflon-lined cap and incubated at 37°C for 30 minutes. The samples were placed in hot water (75°C) for 8 minutes to kill the cells and inactivate HO. CO in the headspace was measured by gas chromatography-mass spectrometry as previously described. 30 Protein was determined by the Lowery method.
Statistical Analysis
Values are presented as meansϮSE. Results were subjected to a 1-way ANOVA for repeated measures with Tukey post hoc test to isolate differences between groups. A level of PϽ0.05 was considered significant. Figure 1 shows effects of topically applied gliotoxin L-2␣AAA (2 mol/L, 5 hours) on isoproterenol-induced (10 Ϫ7 M) and ADP-induced (10 Ϫ4 M) pial arteriolar dilation in vivo. After astrocyte injury, dilation to ADP was blocked, whereas dilation in response to isoproterenol (10 Ϫ7 M), which increases cAMP through vascular smooth muscle ␤-adrenergic receptors, was unaltered (Figure 1) . Similarly, dilations to lower doses of ADP were blocked completely The effects of ADP on aCSF CO concentration before and after treatment with L-2␣AAA (5 hours, 2 mmol/L) are shown in Figure 2 . CO production by the brain surface was detected in the aCSF collected from beneath the cranial window. CO production was increased by ADP. This increase was completely blocked after L-2␣AAA-induced astrocyte injury.
Results
Both sodium nitroprusside (2ϫ10 Ϫ7 M) and ADP (10 Ϫ5 M, 10 Ϫ4 M) caused increases in pial arteriolar diameter ( Figure 3) . The dilation to ADP was blocked by CrMP, the metal porphyrin inhibitor of HO (Figure 3 ). CrMP did not inhibit the vasodilation in response to sodium nitroprusside that dilates by increasing vascular smooth muscle cGMP.
To investigate the possibility that astrocyte-derived CO may play a permissive role in enabling an endotheliumderived relaxing factor-mediated response to ADP, the CO concentration in CSF was elevated by adding 10 ϫ7 M CO to the aCSF after L-AAA injury and the responses to ADP determined. After L-2␣AAA, dilation to ADP was absent (59Ϯ6, 61Ϯ6, and 61Ϯ6 m at 0, 10 Figure 4 ) and cerebral microvessels ( Figure 5 ). CrMP blocked ADPinduced increases in both astrocytes and microvessels. Although ADP increased CO production by both astrocytes and microvessels, the increases caused in astrocytes (59Ϯ7 and 116Ϯ9% at 10 Ϫ5 M and 10 Ϫ4 M ADP) were greater than in microvessels (29Ϯ11% and 80Ϯ13% at 10 Ϫ5 M and 10 Ϫ4 M ADP). The ADP-induced CO production by astrocytes appears to involve activation of P2Y1 receptor because the elevation of CO is blocked by MRS2179 (31Ϯ7 and 7Ϯ5 pmol/mg protein without and with MRS2179, respectively; for 31Ϯ7, PϽ0.05 compared to 0; PϽ0.05 compared to with MRS2179; nϭ7).
Discussion
The major findings in newborn pigs are: (1) treatment with the astrocyte toxin, L-2␣AAA, or the HO inhibitor, CrMP, block pial arteriolar dilation to ADP, but not to isoproterenol, bradykinin, or sodium nitroprusside; (2) ADP increases brain CO production and this increase is blocked by the astrocyte toxin or inhibition of HO; and (3) ADP increases CO production by astrocytes and, to a lesser extent, cerebral microvessels. These data, coupled with previous results showing CO dilates pial arterioles in vivo, suggest CO is an astrocyte-derived mediator of ADP-induced pial arteriolar dilation in piglets.
ADP can produce endothelium-dependent cerebral vasodilation, 19 which may be mediated in part by NO and endothelium-derived hyperpolarizing factor in adult rats. 20, 21, 30 In endothelium-denuded control arteries from rat brain, ADP also produced dose-dependent relaxation, but this relaxation was lower than that found in intact control arteries. 31 In adult rats, ADP-induced pial arteriolar dilation involves the additive effects of an endothelium-dependent and an astrocytedependent component. 22 If the astrocyte component is CO, the response would be endothelial dependent in piglets. Thus, the absence of an effect of L-2␣AAA on pial arteriolar dilation to CO itself, 11 the insensitivity of cerebrovascular endothelial cells to L-2␣AAA in vitro, 11 and dilation to the endothelialdependent dilator, bradykinin, 32 after L-2␣AAA strongly suggest the effects of L-2␣AAA do not result from endothelial injury. CO exhibits its vasoactive actions in conjunction with endothelium-derived relaxing factors that act as permissive enablers. 24, 33 In the piglet cerebral circulation, these permissive enablers include both NO and prostacyclin. 24, 25 The mechanism by which prostacyclin and NO permit the dilatory response to CO appears to be largely attributable to activity of protein kinase G (PKG). 34 However, the ability of NO to partially restore the dilatory response to CO even when guanylyl cyclase is blocked suggests that NO may have actions independent of cGMP. 23, 34 It is also conceivable that astrocyte CO could function as a permissive enabler of responses to an endothelium-derived relaxing factors. Thus, if the astrocyte-derived CO were required for endothelium-derived relaxing factors to cause smooth muscle relaxation, astrocyte injury would block the response even if the final mediator was produced by ADP stimulating endothelium-derived relaxing factors release by endothelium. However, in the case of ADP in newborn pigs, such a permissive role for CO appears unlikely because the addition of CO to the aCSF did not restore dilation to ADP after L-2␣AAA.
In other vascular beds, CO can induce vasodilation that is independent of endothelium. Endothelium-independent vasodilatory mechanisms have been shown in the vasodilatory effect of CO in the rat tail artery, 35 rat thoracic aorta, 36 porcine coronary artery and the vein, 37 and dog carotid and coronary arteries. 38 Astrocytes are critical players in the regulation of cerebral arteriolar diameter including dilation in response to neuronal activity. There are several molecular pathways through which astrocytes can elicit dilation. 39, 40 Locally secreted substances such as adenosine, ADP, or K ϩ act on neighboring blood vessels to cause vasodilation. 41, 42 Piglet glia limitans astrocytes use CO as a messenger to cause cerebral pial arteriole dilation in response to glutamate, which would enhance local blood flow to match increased glutamatergic neuronal activity. 11, 43 In adult rats, NMDA receptor activation of postsynaptic neurons leads to the stimulation of NO synthase to produce NO, which causes vascular smooth muscle relaxation. 44 In the newborn pig cerebral circulation, topical ADP stimulated both CO production and vasodilation of pial arterioles. The inhibitor of HO, CrMP, prevented the ADPinduced increase in CSF CO and the pial arteriolar dilation caused by ADP, but did not block the dilation to sodium nitroprusside. Of note, CrMP did not block pial arteriolar dilation in control adult rats, but did inhibit ADP-induced dilation in rats transfused with cell-free hemoglobin. 45 Clearly, mechanisms of cerebrovascular circulatory dilation may differ with respect to species or age. The ADP-evoked increases in cerebral arteriolar diameter and in CO production in aCSF were abolished after treatment with L-2␣AAA (2 mmol/L, 5 hours). L-2␣AAA is a gliotoxin that can be used as a tool to ablate astrocytes in vitro or in vivo. 11, 26, 27 In the present study, the absence of any direct actions of L-2␣AAA on pial vascular smooth muscle function was shown by the fact that no changes in the response to isoproterenol or sodium nitroprusside were observed in pial arterioles in the presence of L-2␣AAA. ADP also stimulated CO production by isolated astrocytes that was blocked by MRS2179, suggesting involvement to P2Y1 receptors that also cause ADPinduced, astrocyte-dependent, pial arteriolar dilation in adult rats. 22 All these data suggest that astrocytes could deploy CO as a gasotransmitter resulting in cerebrovasodilation in response to ADP.
Of note, we could not detect any L-2␣AAA-induced change in basal CO in the present or previous study. 11 In addition to astrocytes, neurons, endothelial cells, and vascular smooth muscle cells would contribute to the cortical CSF CO concentration. 46 These data suggest the fractional contribution of astrocytes to basal CSF CO concentration is sufficiently small to not be detectable after astrocyte injury.
ADP also increases production of CO in freshly isolated cerebral microvessels but less so than in astrocytes. The microvessels are coated with astrocytes and their processes, 11 so it is uncertain whether the increase in CO is from the vessels, the adhering astrocyte processes, or both. The vasodilator effect of CO has been attributed to both the cGMP/protein kinase G-signaling pathway 47, 48 and activation of K Ca channels. 10, 17, 35 In newborn pig pial arterioles, dilation to CO can be attributed solely to K Ca channels. 46 CO causes smooth muscle hyperpolarization via activation of largeconductance K Ca channels. 17, 49 The binding of CO to heme on the K Ca channels of arteriolar smooth muscle cells 50 increases the Ca sensitivity of K Ca channels. 49 K Ca channels are stimulated by increased local Ca concentrations produced by Ca sparks, and CO increases Ca sparks and the coupling of Ca sparks to K Ca channel openings. 17 In summary, we show that topical ADP increases cerebral production of CO in vivo, dilates pial arterioles, and stimulates CO production by isolated astrocytes. Both ADPinduced production of CO and vasodilation were blocked by astrocyte injury and HO inhibition. These data are consistent with the hypothesis that glia limitans astrocytes use CO as a signaling messenger by which ADP dilates pial arterioles and enhances local blood flow in newborn pigs.
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